Who are Alphalipoic acid's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Silymarin (Silybum marianum), Vitamin E capsule, Vitamin C and E, Ethyl methyl hydroxypyridine succinate + Meldonium, Radicava ORS, Rosiglitazone/alpha-lipoic acid.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/alphalipoic-acid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Alphalipoic acid — Competitive Intelligence Brief

Alphalipoic acid (Alphalipoic acid) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antioxidant. Area: Metabolic/Endocrine.

marketed Antioxidant Metabolic/Endocrine Small molecule Live · refreshed every 30 min

Target snapshot

Alphalipoic acid (Alphalipoic acid) — All India Institute of Medical Sciences, Bhubaneswar. Alpha-lipoic acid is a mitochondrial cofactor that acts as a potent antioxidant and free radical scavenger, reducing oxidative stress in cells.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Alphalipoic acid TARGET	Alphalipoic acid	All India Institute of Medical Sciences, Bhubaneswar	marketed	Antioxidant
Silymarin (Silybum marianum)	Silymarin (Silybum marianum)	University of Maryland, Baltimore	marketed	Herbal extract / Antioxidant
Vitamin E capsule	Vitamin E capsule	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	marketed	Antioxidant vitamin
Vitamin C and E	Vitamin C and E	NICHD Global Network for Women's and Children's Health	marketed	Antioxidant vitamin combination
Ethyl methyl hydroxypyridine succinate + Meldonium	Ethyl methyl hydroxypyridine succinate + Meldonium	Promomed, LLC	marketed	Antioxidant/metabolic enhancer combination
Radicava ORS	Radicava ORS	Shanghai Auzone Biological Technology Co., Ltd.	marketed	Free radical scavenger; antioxidant	Free radicals (hydroxyl radicals); non-selective antioxidant mechanism
Rosiglitazone/alpha-lipoic acid	Rosiglitazone/alpha-lipoic acid	Seoul St. Mary's Hospital	marketed	Thiazolidinedione + antioxidant combination	PPAR-γ (rosiglitazone); mitochondrial oxidative stress (alpha-lipoic acid)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antioxidant class)

All India Institute of Medical Sciences, Bhubaneswar · 1 drug in this class
Hospices Civils de Lyon · 1 drug in this class
Hospital General Universitario Elche · 1 drug in this class
Seoul National University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Alphalipoic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/alphalipoic-acid. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab